MTOR and Insulin resistance: Therefore, there is a molecular link between AD pathology and insulin resistance via mTOR hyperactivation (Barone et al., 2016[6]; Caccamo et al., 2010[12]; Perluigi et al., 2014[58]; Tramutola et al., 2015[82]).